Profil
Nataskia Lampe worked as an Associate Director of Regulatory Affairs at Lung Biotechnology PBC.
She then worked at AbbVie, Inc. as an Asset Strategy Leader for Neuroscience & Fibrosis from 2018 to 2021.
In 2021, she became the Vice President & Head of Regulatory Affairs at Pieris Pharmaceuticals, Inc. Ms. Lampe received her undergraduate degree from Tulane University School of Medicine and her graduate degree from Thomas Jefferson University.
Anciens postes connus de Nataskia Lampe
| Sociétés | Poste | Fin |
|---|---|---|
| PIERIS PHARMACEUTICALS, INC. | Conseiller Juridique Général | 01/08/2022 |
| ABBVIE INC. | Corporate Officer/Principal | 01/08/2021 |
Lung Biotechnology PBC
 Lung Biotechnology PBC Pharmaceuticals: MajorHealth Technology Lung Biotechnology PBC develops pharmaceutical products. It specializes in clinical trials, lung perfusion, and XenoLung. The company was founded by Martine Rothblatt and is headquartered in Silver Spring, MD. | Conseiller Juridique Général | - |
Formation de Nataskia Lampe
| Thomas Jefferson University | Graduate Degree |
| Tulane University School of Medicine | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ABBVIE INC. | Health Technology |
| PIERIS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Lung Biotechnology PBC
Lung Biotechnology PBC Pharmaceuticals: MajorHealth Technology Lung Biotechnology PBC develops pharmaceutical products. It specializes in clinical trials, lung perfusion, and XenoLung. The company was founded by Martine Rothblatt and is headquartered in Silver Spring, MD. | Health Technology |
